Search - tctmd.com

Displaying 41 - 60 of 272

Sort: Relevancy | Date

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News CV Team Pro

Viet Le

L.A. McKeown

July 07, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Todd Neale

June 20, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2023

Shelley Wood

April 28, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Prehospital Troponin Testing With EMS Input Could Save a Lot of Money

Michael O'Riordan

February 07, 2023

Advertisement

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Viet Le

LDL Control Remains Poor in CAD Patients: NHANES

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

FDA Approves Colchicine for Decreasing CV Events

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

TCTMD’s Top 10 Most Popular Stories for April 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

February 2023 News Roundup

Prehospital Troponin Testing With EMS Input Could Save a Lot of Money

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content